Noxopharm Ltd. has released a press release.
Noxopharms Sofra assets to be presented at global conference
Earlier from Noxopharm
- Noxopharm progresses US regulatory strategy
- New data shows SOF-SKN active ingredient efficacy
- Innovative collaboration further expands Sofra platform
- March 2026 Quarterly Activities Report and Appendix 4C